Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in Adolescents

ClinicalTrials.gov ID: NCT00777790

Public ClinicalTrials.gov record NCT00777790. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 20, 2026, 1:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Antibody Responses to a Booster Dose of an Experimental Tetravalent (A, C, Y, and W-135) Meningococcal Diphtheria Toxoid Conjugate Vaccine, Menactra® in Adolescents Who Previously Received Menomune® or Menactra®

Study identification

NCT ID: NCT00777790
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Sanofi Pasteur, a Sanofi Company; Industry
Enrollment: 241 participants

Conditions and interventions

Conditions

Interventions

Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Biological

Biological

Eligibility (public fields only)

Age range: 13 Years to 21 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jan 31, 2004
Primary completion: Mar 31, 2004
Completion: Mar 31, 2005
Last update posted: Feb 13, 2014

2004 – 2005

United States locations

U.S. sites: 9
U.S. states: 7
U.S. cities: 9

Facility	City	State	ZIP	Site status
Not listed	Atlanta	Georgia	30322	—
Not listed	Marietta	Georgia	30062	—
Not listed	Woburn	Massachusetts	01801	—
Not listed	Albany	New York	12208	—
Not listed	Akron	Ohio	44308	—
Not listed	Columbus	Ohio	43205	—
Not listed	Sellersville	Pennsylvania	18960	—
Not listed	Kingsport	Tennessee	37660	—
Not listed	Norfolk	Virginia	23501	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00777790, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 13, 2014 · Synced Jul 20, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00777790 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →